In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Verve Therapeutics Inc (NASDAQ: VERV) closed at $7.03 down -3.43% from its previous closing price of $7.28. In other words, the price has decreased by -$3.43 from its previous closing price. On the day, 1.09 million shares were traded.
Ratios:
For a deeper understanding of Verve Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.05 and its Current Ratio is at 13.05. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 02 ’24 when Dorval Allison sold 555 shares for $5.64 per share. The transaction valued at 3,130 led to the insider holds 5,380 shares of the business.
Ashe Andrew D. bought 76,000 shares of VERV for $475,760 on May 14 ’24. The insider now owns 342,509 shares after completing the transaction at $6.26 per share. On Apr 02 ’24, another insider, Nickerson Joan, who serves as the Chief Administrative Officer of the company, sold 1,514 shares for $8.24 each. As a result, the insider received 12,475 and left with 8,659 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 24.39 while its Price-to-Book (P/B) ratio in mrq is 1.17.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $19.34, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 3.45%, while the 200-Day Moving Average is calculated to be 18.25%.
Shares Statistics:
A total of 84.64M shares are outstanding, with a floating share count of 63.10M. Insiders hold about 25.47% of the company’s shares, while institutions hold 73.27% stake in the company.
